港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

醫藥外包概念

1,672.916

+18.9181.14%

漲家數：6

跌家數：2

平家數：- -

市盈率：- -

高：1,704.072

開：1,667.012

低：1,664.787

收：1,653.998

資料載入中...

瑞銀：升藥明康德目標價至82.5港元評級“買入”

維亞生物盤中異動急速上漲5.52%報1.530港元

藥明康德Q1業績亮眼促CRO概念股集體走強，凱萊英漲近7%

《大行》大摩指藥明康德(02359.HK)首季業績勝預期基本面仍強

阿斯达克财经

藥明康德淨利暴增89%！政策紅利能否催生恒生醫療ETF主升浪？

恒生生物科技ETF漲1.57%，藥明康德漲5.58%

恒指漲幅擴大至1%，恒生科技指數漲2%，阿里健康漲超9%，藥明康德漲超7%

每日经济新闻

藥明康德AH股齊漲，Q1淨利同比大增89%

港股異動藥明康德高開逾5% 一季度歸母淨利同比增近九成維持全年雙位數增長指引

藥明康德(02359)出現大手買入9.67萬股，成交價$62.0，涉資599.54萬

阿斯达克财经

港股創新藥板塊盤初走高，泰凌醫藥(01011.HK)漲近7%，石藥集團(01093.HK)漲超4%，百濟神州(06160

全球創新藥投融資環境有所復甦，港股生物技術板塊集體大漲，藥明康德早盤漲近7%

藥明康德上漲6.44%，報61.95元/股

港股異動 | 石藥集團(01093)漲超3% SYH2068注射液(雙鏈小干擾RNA藥物)獲臨牀試驗批准

石藥集團漲超3% SYH2068注射液(雙鏈小干擾RNA藥物)獲臨牀試驗批准

Q1業績公佈！藥明康德重回兩位數增長

每日经济新闻

港股開盤｜恒指漲0.46%重上22000，蔚來、藥明康德漲超5%

读创客户端

《股市簡訊》中國藥明康德H股勁揚7.2%，一季度淨利同比激增約九成

港股藥明康德(02359.HK)漲超5%，一季度淨利潤36.72億元，同比增長89.06%。

在手訂單攀升，藥明康德2025年業績指引不變

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1576/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"醫藥外包概念","latestPrice":1672.9159,"timestamp":1745914086072,"preClose":1653.9979,"halted":0,"volume":74597219,"delay":0,"changeRate":0.011438,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":18.917969,"latestTime":"04-29 16:00:00","open":1667.0122,"high":1704.0724,"low":1664.7865,"amount":1978384657,"amplitude":0.023752,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745976600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745890200000,1745899200000],[1745902800000,1745913600000]],"pbRate":2.016166,"peRate":9.877416,"turnoverRate":0.006351,"increases":6,"decrements":2,"flats":0,"marketCap":353236529920,"floatMarketCap":156401851520},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":1704.0724,"amplitude":0.023752,"preClose":1653.9979,"low":1664.7865,"pbRate":"2.016166","latestPrice":1672.9159,"volume":74597219,"delay":0,"open":1667.0122,"prevYearClose":1395.7731,"prevWeekClose":1649.561,"prevMonthClose":1941.338,"prevQuarterClose":1941.338,"fiveDayClose":1574.66,"twentyDayClose":1994.557,"sixtyDayClose":1442.983,"secType":"PLATE","market":"HK","turnoverRate":0.006351,"peRate":9.877416,"marketCap":353236529920,"floatMarketCap":156401851520,"timestamp":1745914086072,"nameCN":"醫藥外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":6,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531217498","title":"瑞銀：升藥明康德目標價至82.5港元 評級“買入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2531217498","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531217498?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 10:48","pubTimestamp":1745894891,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["02359","LU2125910500.SGD","603259","BK1583","BK1576","LU0708995583.HKD","LU1997244956.HKD","LU1997245094.SGD","159201","BK0216","LU2045819591.USD","LU2488822045.USD","LU0052750758.USD","LU0320764599.SGD","LU2495084118.USD","LU1046422090.SGD","BK1141","LU2242644610.SGD","LU1997245177.USD","LU0456842615.SGD"],"gpt_icon":0},{"id":"2531217766","title":"維亞生物盤中異動 急速上漲5.52%報1.530港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531217766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531217766?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 10:42","pubTimestamp":1745894577,"startTime":"0","endTime":"0","summary":"2025年04月29日早盘10时42分，维亚生物股票出现波动，股价大幅拉升5.52%。截至发稿，该股报1.530港元/股，成交量43.2万股，换手率0.02%，振幅5.52%。资金方面，该股资金流入52.4805万港元，流出4.01万港元。维亚生物股票所在的生物技术行业中，整体涨幅为2.22%。其相关个股中，中国抗体-B、药明康德、加科思-B涨幅较大，振幅较大的相关个股有中国抗体-B、荣昌生物、药明巨诺-B，振幅分别为28.89%、12.08%、11.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910425794e6c587&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910425794e6c587&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01873","BK1141","BK1576"],"gpt_icon":0},{"id":"2531217793","title":"藥明康德Q1業績亮眼促CRO概念股集體走強，凱萊英漲近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531217793","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531217793?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 10:36","pubTimestamp":1745894160,"startTime":"0","endTime":"0","summary":"药明康德2025年第一季度业绩亮眼，营业收入达96.55亿元，同比增长20.96%，净利润36.72亿元，同比大幅增长89.06%。受此利好消息影响，港股市场CRO板块集体走强，其中凯莱英涨近7%，药明康德涨近6%，维亚生物涨超3%，康龙化成和昭衍新药涨超2%。这一强劲表现不仅提振了投资者信心，也反映了市场对CRO行业前景的乐观预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910382097496244&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910382097496244&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0708995583.HKD","LU0320764599.SGD","02359","LU1046422090.SGD","BK1141","06821","603259","BK1191","BK1576","BK1583","LU0052750758.USD","LU2045819591.USD","LU2242644610.SGD","LU2125910500.SGD"],"gpt_icon":0},{"id":"2531121066","title":"《大行》大摩指藥明康德(02359.HK)首季業績勝預期 基本面仍強","url":"https://stock-news.laohu8.com/highlight/detail?id=2531121066","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531121066?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 10:36","pubTimestamp":1745894160,"startTime":"0","endTime":"0","summary":"摩根士丹利发表研究报告指，药明康德首季收入及非通用会计准则经调整纯利分别录得96.5亿元人民币(下同)及26.8亿元，胜过该行预期。另外，公司持续经营业务积压订单按年扩张47%至523.3亿元，按首季的速度计，约相当于5至6个季度。该行亦提到作为内地的合同开发及生产组织公司，药明康德的基本面依然强劲，即使面临新冠疫情的高基数及地缘政治带来压力下。该行予其H股目标价85港元，评级“增持”。沽空资料截至 2025-04-28 16:25。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20181129150541971_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20181129150541971_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1436614/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1576","LU2495084118.USD","LU2125910500.SGD","603259","LU2045819591.USD","LU1997244956.HKD","LU0320764599.SGD","LU1046422090.SGD","02359","LU2242644610.SGD","BK1141","LU1997245177.USD","BK0216","LU1997245094.SGD","LU0456842615.SGD","BK1583","LU0708995583.HKD","LU0052750758.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2531217795","title":"藥明康德淨利暴增89%！政策紅利能否催生恒生醫療ETF主升浪？","url":"https://stock-news.laohu8.com/highlight/detail?id=2531217795","media":"银柿财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531217795?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 10:34","pubTimestamp":1745894061,"startTime":"0","endTime":"0","summary":"消息面上，药明康德AH股齐涨，A股一度涨超4%至60.54元，H股一度涨超7%至62.4港元。药明康德在报告中表示，营收及归母净利润实现同比增长，主要得益于在保持营业收入增长的同时，不断优化生产工艺和经营效率，以及临床后期和商业化项目增长带来的产能效率提升，提升了整体盈利能力。分业务看，药明康德化学业务同比增幅最大，达到32.87%，其次是生物学业务同比增长8.25%。相关ETF方面，恒生医疗ETF高开高走，盘中大涨超2%，成交额近7亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429103431a46b5701&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429103431a46b5701&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603259","LU0052750758.USD","BK1141","LU2125910500.SGD","BK1576","LU1046422090.SGD","LU2045819591.USD","02359","LU2242644610.SGD","BK1583","LU0708995583.HKD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2531177962","title":"恒生生物科技ETF漲1.57%，藥明康德漲5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531177962","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531177962?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 10:29","pubTimestamp":1745893754,"startTime":"0","endTime":"0","summary":"4月29日，沪深两市震荡回暖。截至10点5分，恒生生物科技ETF(159615.SZ)涨1.57%，药明康德涨5.58%。申万宏源指出，随着创新药审批提速，医保谈判及带量采购政策倾斜本土创新药企，政策红利持续释放。基本面上，人口老龄化与消费升级驱动医疗需求扩容，本土药企研发管线进入收获期，国际化进程提速，创新药出海打开海外市场增量空间。资金面上，南向资金持续加仓港股，流动性支撑显著。板块估值经历深度回调后处于历史低位，安全边际充足，板块配置性价比突出。建议关注恒生生物科技ETF(159615.SZ)，把握行业创新升级与估值修复的双重机遇。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910334794e6c300&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910334794e6c300&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","LU1046422090.SGD","02359","LU0052750758.USD","BK1583","BK1576","LU2045819591.USD","LU0320764599.SGD","LU2242644610.SGD","LU0708995583.HKD","LU2125910500.SGD"],"gpt_icon":0},{"id":"2531217139","title":"恒指漲幅擴大至1%，恒生科技指數漲2%，阿里健康漲超9%，藥明康德漲超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531217139","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531217139?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 10:18","pubTimestamp":1745893136,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月29日，恒指涨幅扩大至1%，恒生科技指数涨2%。医疗保健股涨幅居前，阿里健康涨超9%，药明康德涨超7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://stock.eastmoney.com/a/202504293392518081.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202504293392518081.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0052750758.USD","02833","LU1046422090.SGD","513600","BK1141","BK1584","BK1571","02359","BK1583","LU0708995583.HKD","BK1617","BK1502","BK1247","LU2125910500.SGD","BK1615","YANG","BK1515","LU2242644610.SGD","BK1589","LU0320764599.SGD","BK1501","HHImain","BK1189","HSTECH","BK1576","BK1591","LU2045819591.USD","BK1610","BK1142","BK4614","MCHmain","HSI","00241"],"gpt_icon":0},{"id":"2531211925","title":"藥明康德AH股齊漲，Q1淨利同比大增89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531211925","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531211925?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 10:02","pubTimestamp":1745892158,"startTime":"0","endTime":"0","summary":"药明康德AH股齐涨，A股一度涨超4%至60.54元，H股一度涨超7%至62.4港元。药明康德在报告中表示，营收及归母净利润实现同比增长，主要得益于在保持营业收入增长的同时，不断优化生产工艺和经营效率，以及临床后期和商业化项目增长带来的产能效率提升，提升了整体盈利能力。分业务看，药明康德化学业务同比增幅最大，达到32.87%，其次是生物学业务同比增长8.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910091994e6ba74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910091994e6ba74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","LU2045819591.USD","BK1141","LU0052750758.USD","LU2242644610.SGD","02359","BK1583","LU2125910500.SGD","BK1576","LU0708995583.HKD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2531211912","title":"港股異動 藥明康德高開逾5% 一季度歸母淨利同比增近九成 維持全年雙位數增長指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2531211912","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531211912?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:53","pubTimestamp":1745891630,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药明康德(02359)高开逾5%，截至发稿，涨5.15%，报61.2港元，成交额1438.2万港元。消息面上，药明康德公布2025年第一季度业绩，营业收入约96.55亿元，同比增长20.96%；归属于上市公司股东的净利润约36.72亿元，同比增长89.06%。截至2025年3月末，公司持续经营业务在手订单人民币523.3亿元，同比增长47.1%。药明康德董事长兼首席执行官李革表示，公司目前维持年初制定的全年业绩指引，预计2025年持续经营业务收入将实现10-15%的双位数增长，同时non-IFRS（经调整后的净利润）有望进一步提升。”本文源自：智通财经网","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909561494e6b583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909561494e6b583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","LU2045819591.USD","BK1141","LU0052750758.USD","LU2242644610.SGD","02359","BK1583","LU2125910500.SGD","BK1576","LU0708995583.HKD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2531521182","title":"藥明康德(02359)出現大手買入9.67萬股，成交價$62.0，涉資599.54萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2531521182","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531521182?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:50","pubTimestamp":1745891400,"startTime":"0","endTime":"0","summary":"[大手成交]药明康德(02359)在上午09:50出现大手买入，成交量为9.67万，成交价为港币$62.0，涉资599.54万。至目前为止，股价升6.443%，今日最高价为$62.4，而最低价为$60.55，总成交量为441.539万股，总成交金额港币$2.714亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2504293045/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2495084118.USD","LU1046422090.SGD","LU0456842615.SGD","LU0052750758.USD","BK1576","LU1997245177.USD","LU0320764599.SGD","LU2488822045.USD","02359","603259","BK1583","LU2045819591.USD","LU0708995583.HKD","LU1997245094.SGD","LU2242644610.SGD","BK0216","LU2125910500.SGD","BK1141","LU1997244956.HKD"],"gpt_icon":0},{"id":"2531821605","title":"港股創新藥板塊盤初走高，泰凌醫藥(01011.HK)漲近7%，石藥集團(01093.HK)漲超4%，百濟神州(06160","url":"https://stock-news.laohu8.com/highlight/detail?id=2531821605","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531821605?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:49","pubTimestamp":1745891393,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["603127","LU1008478684.HKD","IE00BZ08YR35.GBP","SG9999004220.SGD","LU0819121731.USD","06978","LU0456846285.SGD","LU1880383366.USD","06160","LU1960683339.HKD","06127","IE0008369823.USD","BK1576","YANG","LU0140636845.USD","LU1720050803.USD","HSTECH","159992","LU0359201612.USD","688235","LU1226287792.SGD","LU0417516738.SGD","LU0708995583.HKD","LU0051755006.USD","IE00B5MMRT66.SGD","LU1226287529.USD","LU1152091754.HKD","LU1226288253.USD","BK4614","LU0880133367.SGD","BK1610","LU1688375341.USD","07226","LU0588546209.SGD","BK1141","HSCEI","LU0823426480.USD","01093","BK1161","IE00B031HY20.USD","LU0856984785.SGD","ONC","01011","LU2328871848.SGD","LU0823426308.USD","LU0516423091.SGD","02269","BK1588","LU0348825331.USD","BK1583"],"gpt_icon":0},{"id":"2531219315","title":"全球創新藥投融資環境有所復甦，港股生物技術板塊集體大漲，藥明康德早盤漲近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531219315","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531219315?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:48","pubTimestamp":1745891280,"startTime":"0","endTime":"0","summary":"　　4月29日消息，港股生物技术板块多股大涨，截至发稿，药明康德、科伦博泰生物涨近6%，创胜集团、来凯医药、乐普生物涨超5%，云顶新耀、中国抗体、康方生物涨超4%。　　消息面上，国投证券发布研报称，全球创新药投融资环境有所复苏，多肽、ADC等细分领域创新研发蓬勃兴起，加速推动CXO行业景气度上行，研发生产外包需求有望逐步改善。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2025-04-29/doc-ineuuwaf5333570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2125910500.SGD","LU2242644610.SGD","HSTECH","LU1997245177.USD","BK1576","LU0320764599.SGD","02359","LU1997244956.HKD","LU0456842615.SGD","BK4614","603259","BK1141","LU1997245094.SGD","HSCEI","BK0216","LU2488822045.USD","BK1583","06978","BK1161","LU1046422090.SGD","159992","BK1574","YANG","LU2495084118.USD","LU2045819591.USD","LU0052750758.USD","LU0708995583.HKD"],"gpt_icon":1},{"id":"2531167312","title":"藥明康德上漲6.44%，報61.95元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531167312","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531167312?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:42","pubTimestamp":1745890934,"startTime":"0","endTime":"0","summary":"4月29日，药明康德(02359)盘中上涨6.44%，截至09:34，报61.95元/股，成交1.33亿元。药明康德提供一体化的新药研发和生产服务，覆盖化学药、生物学研究、临床前测试及临床试验等领域，服务全球超过6,000家合作伙伴。公司通过CRDMO业务模式降低研发门槛，提升研发效率，致力于为全球患者带来创新治疗方案。截至2025年一季报，药明康德营业总收入96.55亿元、净利润35.36亿元。4月28日，2025财年一季报归属股东应占溢利35.36亿人民币，同比增长82.07%，基本每股收益1.24人民币。本文源自：金融界作者：行情君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909433497494dce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909433497494dce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","LU2125910500.SGD","LU0052750758.USD","LU2045819591.USD","BK1141","BK1583","BK1576","LU2242644610.SGD","02359","LU0708995583.HKD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2531545216","title":"港股異動 | 石藥集團(01093)漲超3% SYH2068注射液(雙鏈小干擾RNA藥物)獲臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2531545216","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531545216?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:42","pubTimestamp":1745890923,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，石药集团涨超3%，截至发稿，涨3.48%，报6.25港元，成交额1.77亿港元。消息面上，近日，石药集团发布公告，本集团自主研发的化学1类新药SYH2068注射液(该产品)已获得中华人民共和国国家药品监督管理局批准，可以在中国开展临床试验。临床前研究显示，该产品在药物活性和药效持续性方面优于同类型si RNA产品，展现出药物作用效果持久、安全性好、患者依从性高等差异化优势，具有较高的临床开发价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0008369823.USD","IE0008368742.USD","IE00B5MMRT66.SGD","BK1515","LU1152091168.USD","LU1226288253.USD","IE00B031HY20.USD","LU1226287529.USD","01093","LU0067412154.USD","LU1152091754.HKD","03347","IE00B543WZ88.USD","LU1960683339.HKD","LU0501845795.SGD","BK4505","LU0072913022.USD","BK1141","RNA","BK4139","BK1521","BK1191","SG9999004220.SGD","LU1993786604.SGD","BK1583","IE00BZ08YT58.USD","LU1226287792.SGD","IE00BZ08YS42.EUR","BK4588","BK1576","LU0326950275.SGD","LU0880133367.SGD","LU1008478684.HKD","LU1226287875.USD","LU1807302812.USD","LU0140636845.USD","LU1226288170.HKD","BK4585","LU1951186391.HKD","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2531211983","title":"石藥集團漲超3% SYH2068注射液(雙鏈小干擾RNA藥物)獲臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2531211983","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531211983?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:42","pubTimestamp":1745890920,"startTime":"0","endTime":"0","summary":"石药集团SYH2068注射液获批临床试验，该双链小干扰RNA药物可降低脂蛋白(a)水平，预防动脉粥样硬化，临床前研究显优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909511794e6b3f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909511794e6b3f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0008369823.USD","IE0008368742.USD","IE00B5MMRT66.SGD","BK1515","LU1152091168.USD","LU1226288253.USD","IE00B031HY20.USD","LU1226287529.USD","01093","LU0067412154.USD","LU1152091754.HKD","03347","IE00B543WZ88.USD","LU1960683339.HKD","LU0501845795.SGD","LU0072913022.USD","BK1141","BK1521","BK1191","SG9999004220.SGD","LU1993786604.SGD","BK1583","IE00BZ08YT58.USD","LU1226287792.SGD","IE00BZ08YS42.EUR","LU0326950275.SGD","BK1576","LU0880133367.SGD","LU1008478684.HKD","LU1226287875.USD","LU1807302812.USD","LU0140636845.USD","LU1226288170.HKD","LU1951186391.HKD","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2531758216","title":"Q1業績公佈！藥明康德重回兩位數增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2531758216","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531758216?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:39","pubTimestamp":1745890755,"startTime":"0","endTime":"0","summary":"据药明康德公告，其2025年第一季度收入及利润均重回双位数增长（整体营业收入+21%，持营业务收入+23.1%，归母净利润+89.1%）。全球创新药投融持续复苏背景下，2025Q1公司持续经营业务在手订单同比增长47.1%，在手订单的高速增长，驱动核心业务经营快速改善。在关税扰动背景下，恒生医药近期表现持续强势。近期一季度报告密集发布，荣昌生物、药明康德等业绩利好频传，有望进一步提振医药热度。相关ETF：恒生医药ETF（159892）：持仓药明康德、药明生物、药明合联生物科技ETF（516500）：聚焦医药龙头，药明康德权重近12%每日经济新闻","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429094303a6cc767a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429094303a6cc767a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","LU0052750758.USD","LU2045819591.USD","LU2125910500.SGD","BK1583","LU1046422090.SGD","BK1141","LU0708995583.HKD","BK1576","02359","LU2242644610.SGD"],"gpt_icon":0},{"id":"2531211948","title":"港股開盤｜恒指漲0.46%重上22000，蔚來、藥明康德漲超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531211948","media":"读创客户端","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531211948?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:29","pubTimestamp":1745890159,"startTime":"0","endTime":"0","summary":"观望美国与其他国家的贸易谈判进展及即将出炉的美企业绩，美股周一反复尾盘回稳。港股今早高开，恒指高开0.46%报22073点，恒生科技指数高开0.67%，国企指数高开0.42%。个股方面，蔚来涨超5%领涨恒生科技指数成分股，CEO李斌笃定今年Q4会盈利；理想汽车涨超2%，地平线机器人、舜宇、携程、阿里健康、京东涨超1%；恒指及成分股中，药明康德涨超5%，Q1净利36.72亿元，同比增89.06%；药明生物、申洲国际、中升控股、吉利汽车、蒙牛乳业、周大福涨超1%。来源：读创财经","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909423294e6b024&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909423294e6b024&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0052750758.USD","02833","LU1046422090.SGD","513600","BK1141","BK1588","BK1119","02359","BK1583","LU0708995583.HKD","LU2125910500.SGD","LU2242644610.SGD","LU0320764599.SGD","09866","HHImain","HSTECH","BK1576","LU2045819591.USD","HSI","MCHmain","HSCEI"],"gpt_icon":0},{"id":"2531216538","title":"《股市簡訊》中國藥明康德H股勁揚7.2%，一季度淨利同比激增約九成","url":"https://stock-news.laohu8.com/highlight/detail?id=2531216538","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531216538?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:26","pubTimestamp":1745890005,"startTime":"0","endTime":"0","summary":"《股市简讯》中国药明康德H股劲扬7.2%，一季度净利同比激增约九成* 为制药公司代工研发、生产药物的中国药明康德H股2359.HK周二早盘一度劲扬7.2%，其A股603259.SS升约4.4%；公司一季度净利同比激增约九成。* 恒生香港上市生物科技指数.HSHKBIO盘中涨2%。* 药明康德周一公布，一季度净利同比大增近九成，因产能效率提升，以及出售药明合联部分股权等带来投资收益。* 今年迄今药明康德H股累涨7.6%，其A股累升8.7%。更多股市简讯请点选CN-CMN-HOT  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4S3R702W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997245177.USD","BK1576","BK1141","603259","LU1997244956.HKD","LU2488822045.USD","BK0216","LU2242644610.SGD","LU1997245094.SGD","LU2045819591.USD","LU2125910500.SGD","LU0320764599.SGD","LU0708995583.HKD","02359","LU0052750758.USD","LU2495084118.USD","LU0456842615.SGD","LU1046422090.SGD","BK1583"],"gpt_icon":0},{"id":"2531307213","title":"港股藥明康德(02359.HK)漲超5%，一季度淨利潤36.72億元，同比增長89.06%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531307213","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531307213?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:23","pubTimestamp":1745889804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1576","HSTECH","LU2125910500.SGD","02359","LU2488822045.USD","LU0708995583.HKD","LU1046422090.SGD","BK4614","LU2495084118.USD","LU0320764599.SGD","LU1997245177.USD","BK1141","LU0052750758.USD","LU2045819591.USD","BK0216","LU1997245094.SGD","HSCEI","603259","YANG","LU2242644610.SGD","07226","LU1997244956.HKD","BK1583","LU0456842615.SGD"],"gpt_icon":0},{"id":"2531479213","title":"在手訂單攀升，藥明康德2025年業績指引不變","url":"https://stock-news.laohu8.com/highlight/detail?id=2531479213","media":"中金在线","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531479213?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 08:53","pubTimestamp":1745887989,"startTime":"0","endTime":"0","summary":"尽管过去几个月外部的环境跌宕起伏,但药明康德2025年一季度的收入与利润均重回双位数增长,超越了外部的预期。药明康德表示,公司目前将维持年初制定的全年业绩指引不变,即预计2025年持续经营业务收入将实现双位数增长,同比提升10%-15%,公司整体收入也将直达415-430亿元。药明康德一向对全年经营情况素来有着精准的预判,即使在2024年充满挑战的时期,全年业绩也稳稳落入了指引区间内。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909014397493e9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909014397493e9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","LU2242644610.SGD","LU0052750758.USD","BK1583","LU2125910500.SGD","BK1141","LU1046422090.SGD","LU0708995583.HKD","02359","LU0320764599.SGD","LU2045819591.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}